Theo Ribierre

Employment

• University of Geneva Academic Fellow
  2022 - Present
• Fondation Campus Biotech Geneva Team Head
  2022 - Present
• University of Geneva Postdoctoral Research Assistant
  2021 - 2022
• INSERM PhD Student / Postdoc
  2016 - 2021

Education

• Sorbonne University Interfaculty degree in Therapeutic Innovation
  2018 - 2018
• Sorbonne University PhD
  2016 - 2020
• Université Sorbonne Paris Cité Masters
  2014 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Mosaic human cortical organoids model mTOR-related focal cortical dysplasia through DEPDC5 loss-of-function
  2025 DOI: 10.1101/2025.06.25.661323
  +Save
• Targeting pathological cells with senolytic drugs reduces seizures in neurodevelopmental mTOR-related epilepsy
  Nature Neuroscience 2024 DOI: 10.1038/s41593-024-01634-2
  +Save
• Single-cell genotyping and transcriptomic profiling in focal cortical dysplasia
  2024 DOI: 10.21203/rs.3.rs-4014535/v1
  +Save
• Investigations génétiques et physiopathologiques des dysplasies corticales focales de type 2
  2020 DOI: 10.70675/7ac267e2z8712z4e0fza9a1z424bc9445787
  +Save
• Dissecting the genetic basis of focal cortical dysplasia: a large cohort study
  Acta Neuropathologica 2019 DOI: 10.1007/s00401-019-02061-5
  +Save
• Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia–associated epilepsy
  Journal of Clinical Investigation 2018 DOI: 10.1172/JCI99384
  +Save
• mTOR pathway in familial focal epilepsies
  Oncotarget 2016 DOI: 10.18632/oncotarget.14234
  +Save
• STIM1 controls T cell–mediated immune regulation and inflammation in chronic infection
  Journal of Clinical Investigation 2015 DOI: 10.1172/jci80273
  +Save